David Chu, MD
Ophthalmology · New York, NYNPI 1144260019
Payments from drug & device makers
Across 673 payments — averaging $1804.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mallinckrodt Hospital Products Inc.$910K
- Mallinckrodt Enterprises LLC$146K
- Gilead$64K
- Bausch & Lomb Americas Inc.$47K
- Glaukos Corporation$14K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$7K
- plus $26K from 25 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 128 | $910,429 |
| Mallinckrodt Enterprises LLC | 19 | $145,824 |
| Gilead | 15 | $63,910 |
| Bausch & Lomb Americas Inc. | 91 | $47,261 |
| Glaukos Corporation | 14 | $14,189 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 3 | $6,529 |
| Dompe US, Inc. | 15 | $5,440 |
| Eyepoint US, Inc. | 8 | $5,126 |
| AbbVie(2 entities) | 52 | $4,555 |
| Harrow Eye, LLC | 22 | $3,883 |
| Sun Pharmaceutical Industries Inc. | 99 | $1,502 |
| Sight Sciences, Inc. | 15 | $814 |
| ANI Pharmaceuticals, Inc. | 28 | $641 |
| Oyster Point Pharma, Inc. | 26 | $551 |
| Tarsus Pharmaceuticals, Inc. | 15 | $507 |
| Rxsight Inc | 7 | $456 |
| Alcon | 17 | $390 |
| Novartis | 32 | $382 |
| Amgen(2 entities) | 13 | $339 |
| Ocular Therapeutix, Inc. | 15 | $338 |
| Aerie Pharmaceuticals, Inc. | 6 | $289 |
| Johnson & Johnson Surgical Vision, Inc. | 4 | $277 |
| Kala Pharmaceuticals, Inc. | 15 | $209 |
| Rayner Intraocular Lenses Limited | 1 | $164 |
| Alimera Sciences, Inc. | 2 | $149 |
| Samsara Vision | 1 | $139 |
| NEW World Medical,inc. | 1 | $133 |
| Eyevance Pharmaceuticals LLC | 5 | $85 |
| Biotissue Holdings Inc. | 2 | $43 |
| Beaver-visitec International, Inc. | 1 | $26 |
| Shire North American Group Inc | 1 | $13 |
How this compares
$1,214,592 in reported general payments places this provider in the 95th percentile of 1,587 ophthalmology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in New York
- Douglas JabsNew York$24.3M
- Nathan RadcliffeNew York$2.4M
- Richard SpaideNew York$1.7M
- Jason SlakterNew York$1.2M
- Sharon KehNew York$941K
- Joshua YoungNew York$814K
- Joseph PanarelliNew York$704K
- Joshua KimNew York$677K
- Eric RosenbergNew York$526K
- Ashley BrissetteNew York$452K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.